2-Feb-2026
TipRanks (Sun, 1-Feb 10:31 AM ET)
West to Host Fourth-Quarter and Full-Year 2025 Conference Call
PRNewswire (Thu, 29-Jan 6:00 AM ET)
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
Globe Newswire (Wed, 21-Jan 9:55 AM ET)
West Synchrony S1 Prefillable Syringe System Commercially Available at Pharmapack
PRNewswire (Tue, 20-Jan 6:00 AM ET)
PRNewswire (Mon, 12-Jan 6:00 AM ET)
PRNewswire (Mon, 12-Jan 6:00 AM ET)
West to Participate in Upcoming Investor Conference
PRNewswire (Fri, 12-Dec 6:00 AM ET)
West Declares Quarterly Dividend
PRNewswire (Wed, 10-Dec 6:00 AM ET)
WST Raises Guidance After Strong Third Quarter—HVP Components Fuel Double-Digit Growth
Market Chameleon (Thu, 23-Oct 7:56 AM ET)
West Pharmaceutical Lifts 2025 Outlook on Double-Digit HVP Component Growth and Strong Cash Flow
Market Chameleon (Thu, 23-Oct 4:26 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of February 2, 2026, WST stock price climbed to $237.50 with 1,042,042 million shares trading.
WST has a beta of 0.84, meaning it tends to be less sensitive to market movements. WST has a correlation of 0.07 to the broad based SPY ETF.
WST has a market cap of $17.09 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $805 million in Revenue and $1.96 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.28.
In the last 3 years, WST traded as high as $415.73 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, VUG, IVV.
WST has underperformed the market in the last year with a price return of -30.6% while the SPY ETF gained +16.1%. WST has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.6% and -8.5%, respectively, while the SPY returned +2.6% and +0.5%, respectively.
WST support price is $225.30 and resistance is $236.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.